OpenAlex
PricingAboutJobs
Log inGet started
Work

Outcomes of Vdpace for Relapsed/Refractory Multiple Myeloma in the Era of Daratumumab Based Therapy

HTML PDF

Year: 2023
Type: conference-abstract
Source: Blood
DOI: 10.1182/blood-2023-188117
Authors: Priyanka Venkatesh, Ghena Khasawneh, Hamza Hashmi, Omar Alkharabsheh, Barry Paul, Barry S. Skikne, Zahra Mahmoudjafari, Nausheen Ahmed, Al-Ola Abdallah, Shebli Atrash
Institutions: University of Kansas Medical Center, Jordan University of Science and Technology, Medical University of South Carolina, MUSC Hollings Cancer Center, University of South Alabama, Levine Cancer Institute
Language: English

Topic: Multiple Myeloma Research and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: relapsed/refractory multiple myeloma, salvage therapy, daratumumab, bortezomib, doxorubicin, cisplatin, cyclophosphamide, etoposide, dexamethasone, progression-free survival, overall survival, treatment safety, adverse events, real-world outcomes
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W4389247243
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security